Inhalative Application Of Synthetic Cyclic Peptide Ap301 Improves Lung Function During Ex Vivo Lung Perfusion

Objective: Ex vivo lung perfusion (EVLP) has emerged as a new technique to evaluate and improve marginal donor lungs prior to transplantation. The synthetic cyclic peptide AP301 has been shown to reduce oedema formation and neutrophile count in the air space in acute lung injury. We sought to investigate[for full text, please go to the a.m. URL]
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Thoraxchirurgie